Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9931 | 1106 | 44.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
2204 | 2 | MIBEFRADIL//T TYPE CALCIUM CHANNEL//CALCIUM CHANNELS | 4862 |
9931 | 1 | MIBEFRADIL//T TYPE CALCIUM CHANNEL//T TYPE CA2 CHANNEL | 1106 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MIBEFRADIL | authKW | 2651298 | 13% | 65% | 147 |
2 | T TYPE CALCIUM CHANNEL | authKW | 2331248 | 14% | 56% | 151 |
3 | T TYPE CA2 CHANNEL | authKW | 959334 | 6% | 50% | 69 |
4 | T TYPE | authKW | 575178 | 4% | 53% | 39 |
5 | CAV32 | authKW | 491891 | 3% | 64% | 28 |
6 | T TYPE CHANNEL | authKW | 441700 | 2% | 67% | 24 |
7 | T TYPE CALCIUM CHANNEL BLOCKERS | authKW | 419917 | 2% | 89% | 17 |
8 | LOW VOLTAGE ACTIVATED | authKW | 357780 | 2% | 72% | 18 |
9 | EFONIDIPINE | authKW | 324516 | 2% | 51% | 23 |
10 | 3 4 DIHYDROQUINAZOLINE | authKW | 265025 | 1% | 80% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Physiology | 3006 | 19% | 0% | 205 |
2 | Pharmacology & Pharmacy | 2047 | 27% | 0% | 294 |
3 | Neurosciences | 1454 | 23% | 0% | 252 |
4 | Cardiac & Cardiovascular System | 1108 | 13% | 0% | 149 |
5 | Peripheral Vascular Diseases | 867 | 9% | 0% | 98 |
6 | Chemistry, Medicinal | 438 | 7% | 0% | 73 |
7 | Cell Biology | 235 | 9% | 0% | 104 |
8 | Biochemistry & Molecular Biology | 76 | 12% | 0% | 129 |
9 | Biophysics | 59 | 4% | 0% | 42 |
10 | Hematology | 41 | 3% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEP S CIRCADIAN DISORDERS | 84539 | 1% | 44% | 7 |
2 | S EXCELLENCE ION CHANNEL SCI THER EUT | 84539 | 1% | 44% | 7 |
3 | CNRSUMR 5203 | 66250 | 1% | 40% | 6 |
4 | INTERDISCIPLINARY PROGRAM BIOTECHNOL | 66250 | 1% | 40% | 6 |
5 | CNRSUMR 5203IGF PHYSIOL | 55214 | 0% | 100% | 2 |
6 | DRUG DISCOVERY CHEM BIOL PHARMACOL | 55214 | 0% | 100% | 2 |
7 | FEDERATIF RECH 3 | 49691 | 0% | 60% | 3 |
8 | QA RA PHARMACOVIGILANCE | 40151 | 0% | 36% | 4 |
9 | NEURONAL SIGNALING | 35492 | 0% | 43% | 3 |
10 | U661 | 35131 | 2% | 6% | 20 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 10839 | 5% | 1% | 57 |
2 | CHANNELS | 7578 | 1% | 2% | 12 |
3 | CELL CALCIUM | 6003 | 2% | 1% | 25 |
4 | MOLECULAR PAIN | 2588 | 1% | 1% | 9 |
5 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2068 | 3% | 0% | 29 |
6 | JOURNAL OF PHYSIOLOGY-LONDON | 1902 | 3% | 0% | 36 |
7 | MOLECULAR PHARMACOLOGY | 1730 | 2% | 0% | 25 |
8 | JOURNAL OF PHARMACOLOGICAL SCIENCES | 1416 | 1% | 0% | 11 |
9 | CIRCULATION RESEARCH | 1411 | 2% | 0% | 23 |
10 | CARDIOVASCULAR DRUGS AND THERAPY | 1408 | 1% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIBEFRADIL | 2651298 | 13% | 65% | 147 | Search MIBEFRADIL | Search MIBEFRADIL |
2 | T TYPE CALCIUM CHANNEL | 2331248 | 14% | 56% | 151 | Search T+TYPE+CALCIUM+CHANNEL | Search T+TYPE+CALCIUM+CHANNEL |
3 | T TYPE CA2 CHANNEL | 959334 | 6% | 50% | 69 | Search T+TYPE+CA2+CHANNEL | Search T+TYPE+CA2+CHANNEL |
4 | T TYPE | 575178 | 4% | 53% | 39 | Search T+TYPE | Search T+TYPE |
5 | CAV32 | 491891 | 3% | 64% | 28 | Search CAV32 | Search CAV32 |
6 | T TYPE CHANNEL | 441700 | 2% | 67% | 24 | Search T+TYPE+CHANNEL | Search T+TYPE+CHANNEL |
7 | T TYPE CALCIUM CHANNEL BLOCKERS | 419917 | 2% | 89% | 17 | Search T+TYPE+CALCIUM+CHANNEL+BLOCKERS | Search T+TYPE+CALCIUM+CHANNEL+BLOCKERS |
8 | LOW VOLTAGE ACTIVATED | 357780 | 2% | 72% | 18 | Search LOW+VOLTAGE+ACTIVATED | Search LOW+VOLTAGE+ACTIVATED |
9 | EFONIDIPINE | 324516 | 2% | 51% | 23 | Search EFONIDIPINE | Search EFONIDIPINE |
10 | 3 4 DIHYDROQUINAZOLINE | 265025 | 1% | 80% | 12 | Search 3+4+DIHYDROQUINAZOLINE | Search 3+4+DIHYDROQUINAZOLINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TODOROVIC, SM , JEVTOVIC-TODOROVIC, V , (2011) T-TYPE VOLTAGE-GATED CALCIUM CHANNELS AS TARGETS FOR THE DEVELOPMENT OF NOVEL PAIN THERAPIES.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 163. ISSUE 3. P. 484 -495 | 81 | 71% | 65 |
2 | PEREZ-REYES, E , (2003) MOLECULAR PHYSIOLOGY OF LOW-VOLTAGE-ACTIVATED T-TYPE CALCIUM CHANNELS.PHYSIOLOGICAL REVIEWS. VOL. 83. ISSUE 1. P. 117-161 | 130 | 30% | 891 |
3 | BOURINET, E , FRANCOIS, A , LAFFRAY, S , (2016) T-TYPE CALCIUM CHANNELS IN NEUROPATHIC PAIN.PAIN. VOL. 157. ISSUE 2. P. S15 -S22 | 78 | 53% | 4 |
4 | HANSEN, PBL , (2015) FUNCTIONAL IMPORTANCE OF T-TYPE VOLTAGE-GATED CALCIUM CHANNELS IN THE CARDIOVASCULAR AND RENAL SYSTEM: NEWS FROM THE WORLD OF KNOCKOUT MICE.AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. VOL. 308. ISSUE 4. P. R227 -R237 | 71 | 65% | 6 |
5 | HUC, S , MONTEIL, A , BIDAUD, I , BARBARA, G , CHEMIN, J , LORY, P , (2009) REGULATION OF T-TYPE CALCIUM CHANNELS: SIGNALLING PATHWAYS AND FUNCTIONAL IMPLICATIONS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1793. ISSUE 6. P. 947 -952 | 62 | 84% | 26 |
6 | ZHANG, Y , JIANG, XH , SNUTCH, TP , TAO, J , (2013) MODULATION OF LOW-VOLTAGE-ACTIVATED T-TYPE CA2+ CHANNELS.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1828. ISSUE 7. P. 1550-1559 | 78 | 58% | 17 |
7 | LI, M , HANSEN, JB , HUANG, L , KEYSER, BM , TAYLOR, JT , (2005) TOWARDS SELECTIVE ANTAGONISTS OF T-TYPE CALCIUM CHANNELS: DESIGN, CHARACTERIZATION AND POTENTIAL APPLICATIONS OF NNC 55-0396.CARDIOVASCULAR DRUG REVIEWS. VOL. 23. ISSUE 2. P. 173-196 | 82 | 69% | 34 |
8 | GIORDANETTO, F , KNERR, L , WALLBERG, A , (2011) T-TYPE CALCIUM CHANNELS INHIBITORS: A PATENT REVIEW.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 21. ISSUE 1. P. 85 -101 | 45 | 90% | 25 |
9 | MCGIVERN, JG , (2006) PHARMACOLOGY AND DRUG DISCOVERY FOR T-TYPE CALCIUM CHANNELS.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 5. ISSUE 6. P. 587 -603 | 108 | 44% | 27 |
10 | ZHANG, Y , WANG, H , QIAN, ZY , FENG, B , ZHAO, XY , JIANG, XH , TAO, J , (2014) LOW-VOLTAGE-ACTIVATED T-TYPE CA2+ CHANNEL INHIBITORS AS NEW TOOLS IN THE TREATMENT OF GLIOBLASTOMA: THE ROLE OF ENDOSTATIN.PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. VOL. 466. ISSUE 4. P. 811-818 | 52 | 72% | 3 |
Classes with closest relation at Level 1 |